A woman lifting a dumbell

Know now* with Guardant Reveal®

From the company with more than a decade of experience in ctDNA testing, Guardant Reveal provides earlier, clearer answers about cancer—so you can move forward with confidence.

About Guardant Reveal

“Do I still have cancer?”“Could it be coming back?”“Is my treatment working?”

Get your questions answered. Guardant Reveal can find small pieces of cancer DNA, called ctDNA (circulating tumor DNA), in your blood, often before changes show up on a scan or symptoms appear.†

Knowing this information earlier helps you and your care team stay a step ahead.

Reasons to choose Guardant Reveal

Proven

Backed by rigorous scientific studies.1-3

Accurate

Analyzes thousands of unique signals linked to cancer.

Easy

Ongoing testing is done through a simple blood draw.

Timely

Learn what may be happening in your body before it shows up on a scan or symptoms appear.†

Getting tested with Guardant Reveal is easy

How it works:

Sample collection

A simple blood draw is completed at your doctor’s office or with mobile phlebotomy. A previously collected tissue sample may also be tested.

Lab analysis

Advanced ctDNA analysis of your sample is completed at the Guardant Health lab.

Results

Your care team will review your results with you. Initial results are typically delivered in a week* and additional results, if applicable, follow 2–3 weeks later.

Ongoing testing

Requires only a simple blood draw and helps track important changes to ctDNA over time.

Set up your myGuardant Patient Portal account to view your results.

Get started

Community stories

Hear what other patients and advocates have to say about Guardant Reveal.

I had a Guardant Reveal test done recently, and I saw the results (no ctDNA detected). That meant more to me than anything else, because that meant no cancer detected.
—Kim, survivor, colorectal cancer

Our partnerships

We’re proud to partner with organizations that support and advocate for patients.

Colon Cancer CoalitionGO2 for Lung CancerSusan G. Komen

Frequently asked questions
about Guardant Reveal

Click on each question to learn more.

Cancer cells can release tiny pieces of their DNA into the blood, called ctDNA. Guardant Reveal looks for ctDNA in your blood to help detect cancer, monitor it over time, and guide treatment decisions.
MRD is a small amount of cancer, also called residual disease, that may remain in your body after treatment and is often too small to be seen on a scan. Guardant Reveal looks for ctDNA in your blood to help detect signs of residual disease or recurrence, potentially before cancer appears on a scan or causes symptoms.†
Guardant Reveal is available for a wide range of cancers and can be used at different points in your care. After treatment, it can help detect signs that cancer may still be present or is coming back. During treatment, it can help you and your care team understand how well your cancer is responding over time.
Guardant Reveal is used alongside scans and other tests to provide more information about your cancer. Testing over time can help you and your care team track important changes and discuss whether any adjustments to your care plan may be needed.
Guardant Reveal requires a prescription from your doctor. Once the test is ordered, your care team will help schedule your blood draw.
You can have your blood drawn at your doctor’s office or, for added flexibility, use Guardant’s mobile phlebotomy service to have your blood drawn at a location that works for you. There is no additional cost for this service.‡ To learn more about mobile phlebotomy, call us at 1.855.698.8887.
Guardant Reveal can be done using a blood sample alone. In some cases, your doctor may also use a previously collected tissue sample from your tumor to personalize the test to your cancer. Your doctor will determine which approach is right for you.
How often you get tested depends on your cancer and why your doctor has ordered Guardant Reveal. Some people may be tested every 1–6 months, and testing can continue for 5 years or longer after diagnosis because your cancer and care needs can change over time. Talk with your doctor about how often you should get tested and for how long.
Initial results are typically delivered in a week* and additional results, if applicable, follow 2–3 weeks later.
Your results will be sent to your care team and posted to your myGuardant Patient Portal. You’ll receive an email when they’re ready to view. Your care team will discuss your results with you, explain what they mean for your care, and answer any questions you may have.

Set up your myGuardant account by visiting Portal.GuardantHealth.com​/MyGuardant or downloading the app on your phone.

In your portal, you can:

  • Check the status of your test
  • View and download your results
  • Choose how you’d like future blood draws done—in-clinic or at a location of your choice through our mobile phlebotomy service
Guardant Reveal test results will show either “ctDNA detected” or “ctDNA not detected.” If your doctor orders an additional test personalized to your tumor tissue, your final report may show both results. Your care team will review your results with you and explain what they mean for your care.
Cost may vary depending on your Medicare or insurance plan and coverage. If you need additional assistance, our Guardant Access Program helps minimize out-of-pocket costs, checks if you qualify for financial assistance, and handles the insurance and billing process. Ask your care team to provide the patient consent form to enroll in the program at no cost to you.
If you have Medicare, you may be asked to sign an Advance Beneficiary Notice (ABN) before testing. Signing it does not commit you to a specific cost, and you can still receive support through the Guardant Access Program.
Your insurance company may send you an Explanation of Benefits (EOB). This document explains how your insurance processed the test. It is not a bill.

Patient resources

We’ve got you covered every step of the way.

The Guardant Access Program

We are here for you. Our support program can assist with coverage and financial assistance.

Learn more

Flexible Blood Draw Options

Save a trip to the clinic. Our mobile phlebotomy service can come to you at no additional cost.

Learn more

*Blood draw median turnaround time from sample receipt to results released to the ordering provider is a week.

†In the COSMOS study, the test found ctDNA in the blood about 5 months (and up to 28.7 months) before the cancer’s return was found by other methods.

‡Guardant offers mobile phlebotomy services across most of the United States. Check with your care team to confirm availability in your area.

References: 1. Nakamura Y, et al. Clin Can Res. 2024. 2. Ademuyiwa FO, et al. Clin Cancer Res. 2025. 3. Elliott MJ, et al. ESMO Open. 2025.